Intellectus Partners’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Intellectus Partners’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-13,000	Closed	-$35K	–	570
2018 Q3	$35K	Hold	13,000	–	–	0.01%	379
2018 Q2	$25K	Hold	13,000	–	–	0.01%	406
2018 Q1	$27K	Hold	13,000	–	–	0.01%	401
2017 Q4	$26K	Hold	13,000	–	–	0.01%	406
2017 Q3	$17K	Hold	13,000	–	–	0.01%	565
2017 Q2	$20K	Hold	13,000	–	–	0.01%	514
2017 Q1	$42K	Buy	+13,000	New	+$32K	0.02%	363

Other funds holding INFI

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

First Eagle Investment Management

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return